ROCKVILLE, Md., Feb. 10, 2011 /PRNewswire/ -- Ariadne, a leader in bioinformatics software and knowledge integration, announces today that Georgetown University signed a site license for the use of Pathway Studio® software. In continuing its goal of adopting and applying innovative technologies, Georgetown Lombardi Comprehensive Cancer Center will employ Pathway Studio to aid researchers in their efforts to unravel cancer disease biology, disease progression, and translational medicine. These research findings will be shared using Pathway Studio through the Georgetown Database of Cancer (G-DOC) initiative.
"Translational medicine has become increasingly important as an investigative tool to help identify biomarkers and surrogate markers involved with disease or therapeutic response. Finding tools that can help integrate published findings with our microRNA experimental data is exciting as this advancement will enhance our ability to create disease models and hypotheses more rapidly and with greater accuracy," states Dr. Subha Madhavan, Director of Clinical Research Informatics at Georgetown Lombardi.
"Ariadne's expertise in developing biological knowledgebases for disease modeling fits nicely into Georgetown Lombardi's vision and goals. We look to help them achieve greater understanding of cancer and to apply these discoveries to have the greatest impact in translational medicine," states Ilya Mazo, president of Ariadne.
Pathway Studio's workflow approach allows researchers to mine, integrate, analyze and visualize results individually or as an integrated workflow. Each step can be saved, then updated or modified as new information becomes available. Separate analyses can be combined or intersected for advanced applications and discovery.
For more information about Pathway Studio and Ariadne, visit the Ariadne website at
Copyright©2010 PR Newswire.
All rights reserved